| Literature DB >> 34253410 |
Rajapandian Siva Ganesa Karthikeyan1, Gunasekaran Rameshkumar2, Chidambaranathan Gowri Priya3, Prajna Lalitha2, Ramamoorthi Devi4, Mani Iswarya4, Ravilla D Ravindran5.
Abstract
PURPOSE: Health care workers are at higher risk of acquiring the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This study aims to understand the seroprevalence of anti-SARS-CoV-2 IgG antibody among the eye care workers in South India.Entities:
Keywords: ELISA; Eye care workers; Health care workers; IgG antibody; SARS-CoV-2; Seroprevalence
Mesh:
Substances:
Year: 2021 PMID: 34253410 PMCID: PMC8270789 DOI: 10.1016/j.ijmmb.2021.06.014
Source DB: PubMed Journal: Indian J Med Microbiol ISSN: 0255-0857 Impact factor: 0.985
Sociodemographic characteristic of 1313 eye care workers.
| s.no | Details | n | % | |
|---|---|---|---|---|
| Madurai | 457 | 34.8 | ||
| Coimbatore | 314 | 23.9 | ||
| Pondicherry | 203 | 15.5 | ||
| Chennai | 87 | 6.6 | ||
| 6. | Tirunelveli | 85 | 6.5 | |
| 7. | Tirupati | 51 | 3.9 | |
| 8. | Salem | 20 | 1.5 | |
| 9. | Theni | 63 | 4.8 | |
| 10. | Dindigul | 33 | 2.5 | |
| Female | 932 | 71.0 | ||
| 12. | Male | 381 | 29.0 | |
| 13. | <20 | 148 | 11.3 | |
| 14. | 21–30 | 365 | 27.8 | |
| 15. | 31–40 | 262 | 20.0 | |
| 16. | 41–50 | 275 | 20.9 | |
| 17. | 51–60 | 164 | 12.5 | |
| 18. | >60 | 99 | 7.5 | |
| 19. | Accounts | 16 | 1.2 | |
| 20. | Administration | 171 | 13.0 | |
| 21. | Catering | 14 | 1.1 | |
| 22. | Cleaner | 65 | 5.0 | |
| 23. | Counseling | 51 | 3.9 | |
| 24. | House Keeping | 86 | 6.5 | |
| 25. | Laboratory | 30 | 2.3 | |
| 26. | Maintenance | 75 | 5.7 | |
| 27. | Medical consultant | 138 | 10.5 | |
| 28. | Medical Records | 75 | 5.7 | |
| 29. | Out Patients | 138 | 10.5 | |
| 30. | Optical | 37 | 2.8 | |
| 31. | Operation Theatre | 205 | 15.6 | |
| 32. | Pharmacy | 13 | 1.0 | |
| 33. | Refraction | 42 | 3.2 | |
| 34. | Security | 61 | 4.6 | |
| 35. | Store | 12 | 0.9 | |
| 36. | Transport | 35 | 2.7 | |
| 37. | Ward | 49 | 3.7 | |
| 38. | High | 791 | 60.2 | |
| 39. | Moderate | 226 | 17.2 | |
| 40. | Low | 296 | 22.5 | |
| 41. | Hostel | 467 | 35.6 | |
| 42. | Day scholar | 846 | 64.4 | |
| 43. | ||||
| fever | 87 | 6.6 | ||
| 45. | cough | 50 | 3.8 | |
| 46. | Nasal discharge | 36 | 2.7 | |
| 47. | Sore Throat | 58 | 4.4 | |
| 48. | Anosmia or hypogeusia | 22 | 1.7 | |
| 49. | Breathlessness | 8 | 0.6 | |
| 50. | Headache | 36 | 2.7 | |
| 51. | Chest pain | 2 | 0.2 | |
| 52. | Nausea | 4 | 0.3 | |
| 53. | Vomiting | 4 | 0.3 | |
| 54. | Diarrhoea | 8 | 0.6 | |
| 55. | Body ache | 36 | 2.7 | |
| 56. | Fatigue | 12 | 0.9 | |
| 57. | ||||
| Lung disease | 12 | 0.9 | ||
| 59. | Liver disease | 2 | 0.2 | |
| 60. | Diabetes | 87 | 6.6 | |
| 61. | Hypertension | 42 | 3.2 | |
| 62. | Renal disease | 1 | 0.1 | |
| 63. | Malignancy | 2 | 0.2 | |
| 64. | Heart disease | 11 | 0.8 | |
one individual may have more than one associated symptom or illness.
SARS-CoV-2IgG antibody prevalence for different sociodemographic characteristics.
| S. no | Details | Positive | % | Negative | % | Total | |
|---|---|---|---|---|---|---|---|
| 1. | 1313 | ||||||
| 2. | <20 | 16 | 10.8 | 132 | 89.2 | 148 | |
| 3. | 21–30 | 39 | 10.7 | 326 | 89.3 | 365 | |
| 4. | 31–40 | 46 | 17.6 | 216 | 82.4 | 262 | |
| 5. | 41–50 | 63 | 22.9 | 212 | 77.1 | 275 | |
| 6. | 51–60 | 30 | 18.3 | 134 | 81.7 | 164 | |
| 7. | >60 | 13 | 13.1 | 86 | 86.9 | 99 | |
| 8. | Female | 150 | 16.1 | 782 | 83.9 | 932 | |
| 9. | Male | 57 | 15.0 | 324 | 85.0 | 381 | |
| 10. | Accounts | 2 | 12.5 | 14 | 87.5 | 16 | |
| 11. | Administration | 39 | 22.8 | 132 | 77.2 | 171 | |
| 12. | Catering | 4 | 28.6 | 10 | 71.4 | 14 | |
| 13. | Cleaner | 7 | 10.8 | 58 | 89.2 | 65 | |
| 14. | Counseling | 11 | 21.6 | 40 | 78.4 | 51 | |
| 15. | House Keeping | 14 | 16.3 | 72 | 83.7 | 86 | |
| 16. | Laboratory | 4 | 13.3 | 26 | 86.7 | 30 | |
| 17. | Maintenance | 13 | 17.3 | 62 | 82.7 | 75 | |
| 18. | Medical consultant | 9 | 6.5 | 129 | 93.5 | 138 | |
| 19. | Medical Records | 16 | 21.3 | 59 | 78.7 | 75 | |
| 20. | Out Patients | 19 | 13.8 | 119 | 86.2 | 138 | |
| 21. | Optical | 7 | 18.9 | 30 | 81.1 | 37 | |
| 22. | Operation Theatre | 27 | 13.2 | 178 | 86.8 | 205 | |
| 23. | Pharmacy | 4 | 30.8 | 9 | 69.2 | 13 | |
| 24. | Refraction | 5 | 11.9 | 37 | 88.1 | 42 | |
| 25. | Security | 9 | 14.8 | 52 | 85.2 | 61 | |
| 26. | Store | 2 | 16.7 | 10 | 83.3 | 12 | |
| 27. | Transport | 9 | 25.7 | 26 | 74.3 | 35 | |
| 28. | Ward | 6 | 12.2 | 43 | 87.8 | 49 | |
| 29. | High | 108 | 13.7 | 683 | 86.3 | 791 | |
| 30. | Moderate | 44 | 19.5 | 182 | 80.5 | 226 | |
| 31. | Low | 55 | 18.6 | 241 | 81.4 | 296 | |
| 32. | Hostel | 45 | 9.6 | 422 | 90.4 | 467 | |
| 33. | Day scholar | 162 | 19.1 | 684 | 80.9 | 846 | |
| 34. | 1: Symptomatic COVID positive person | 6 | 85.71 | 1 | 14.29 | 7 | |
| 35. | 2: Asymptomatic COVID positive person | 2 | 100.00 | 0 | 0.00 | 2 | |
| 36. | 3: Asymptomatic direct contact of lab confirmed COVID positive person | 9 | 23.08 | 30 | 76.92 | 39 | |
| 37. | 4: Symptomatic Influenza like Illness (ILI) person (since 1st April 2020) | 51 | 38.35 | 82 | 61.65 | 133 | |
| 38. | 5: Asymptomatic direct contact of Symptomatic Influenza like Illness (ILI) person | 7 | 24.14 | 22 | 75.86 | 29 | |
| 39. | 6: Asymptomatic Non-COVID person | 132 | 11.97 | 971 | 88.03 | 1103 | |
| 40. | 12 | 16.4 | 61 | 83.6 | 73 | ||
| 41. | |||||||
| 42. | Fever | 43 | 49.4 | 44 | 50.6 | 87 | |
| 43. | Cough | 22 | 44.0 | 28 | 56.0 | 50 | |
| 44. | Nasal discharge | 15 | 41.7 | 21 | 58.3 | 36 | |
| 45. | Sore throat | 18 | 31.0 | 40 | 69.0 | 58 | |
| 46. | Anosmia or hypogeusia | 16 | 72.7 | 6 | 27.3 | 22 | |
| 47. | Breathlessness | 5 | 62.5 | 3 | 37.5 | 8 | |
| 48. | Headache | 18 | 50.0 | 18 | 50.0 | 36 | |
| 49. | Chest pain | 1 | 50.0 | 1 | 50.0 | 2 | |
| 50. | Nausea | 2 | 50.0 | 2 | 50.0 | 4 | |
| 51. | Vomiting | 2 | 50.0 | 2 | 50.0 | 4 | |
| 52. | Diarrhoea | 4 | 50.0 | 4 | 50.0 | 8 | |
| 53. | Body ache | 17 | 47.2 | 19 | 52.8 | 36 | |
| 54. | Fatigue | 6 | 50.0 | 6 | 50.0 | 12 | |
| 55. | |||||||
| 56. | Lung disease | 2 | 16.7 | 10 | 83.3 | 12 | |
| 57. | Liver disease | 1 | 50.0 | 1 | 50.0 | 2 | |
| 58. | Diabetes | 25 | 28.7 | 62 | 71.3 | 87 | |
| 59. | Hypertension | 10 | 23.8 | 32 | 76.2 | 42 | |
| 60. | Renal disease | 1 | 100.0 | 0 | 0.0 | 1 | |
| 61. | Malignancy | 0 | 0.0 | 2 | 100.0 | 2 | |
| 62. | Heart disease | 5 | 45.5 | 6 | 54.5 | 11 | |
| 63. | 16 | 51.6 | 15 | 48.4 | 31 | ||
one individual may have more than one associated symptom or illness.
Fig. 1Seroprevalence of SARS-CoV-2antibodies across the eye care workers in nine centres of Aravind Eye Care System.
Fig. 2Prevalence of the anti-SARS-CoV-2IgG antibody among the eye care workers with reference to A) Age and B) Departments.
Fig. 3A) Percentage of seropositivity among difference risk groups. Department wise distribution of percentage seropositivity among different risk groups -B) high C) moderate and D) low risk categories (HK- Housekeeping, MRD – Medical Records department, OT-operation theatre, OPD – Outpatient department).